Coronavirus channel feed

Biden's fight with Mod­er­na over pro­vid­ing vac­cines for the poor­est coun­tries in­ten­si­fies

4 years ago

J&J pro­pos­es slid­ing boost­er time­lines as FDA ques­tions lack of da­ta for Delta, old­er adults be­fore ad­comm

4 years ago
FDA+

As TRIPS coun­cil meets, the IP waiv­er for vac­cines is on life sup­port ahead of a De­cem­ber dead­line

4 years ago
Pharma

Cure­Vac spins a ma­jor set­back on their mR­NA Covid vac­cine in­to an ad­van­tage in the mar­ket wars to come

4 years ago
R&D

FDA still is­n't re­al­ly throw­ing its weight be­hind Covid-19 vac­cine boost­ers, Mod­er­na's ad­comm brief­ing docs show

4 years ago

Covid-19 roundup: Ex­perts wor­ry mol­nupi­ravir de­mand will leave poor coun­tries be­hind as Mer­ck says it will dou­ble pro­duc­tion

4 years ago

Sci­en­tist be­hind Mer­ck­'s Covid pill: We need to watch out for re­sis­tance

4 years ago
R&D

GSK and Vir turn to US for dis­tri­b­u­tion as Covid-19 mAb treat­ment nears block­buster sta­tus

4 years ago

Covid-19 roundup: Mer­ck sub­mits mol­nupi­ravir for EUA; In­dia re­sumes vac­cine ex­ports af­ter Delta surge

4 years ago

Af­ter fil­ing for au­tho­riza­tion of its Covid-19 an­ti­body as a pro­phy­lac­tic, As­traZeneca pulls out new da­ta in the treat­ment set­ting

4 years ago
R&D

Lu­men lands an­oth­er DoD con­tract to treat Covid-re­lat­ed GI is­sues

4 years ago
Deals

Covid-19 roundup: Pfiz­er, BioN­Tech seek au­tho­riza­tion of vac­cine for 5- to 11-year-olds; Fin­land halts roll­out of Mod­er­na vac­cine in younger men — re­port

4 years ago

As con­ti­nen­t's vac­ci­na­tion rate sits be­low 5%, Mod­er­na an­nounces in­vest­ment in mR­NA man­u­fac­tur­ing in Africa

4 years ago
Deals
Manufacturing

Sanofi, Mod­er­na beef up the case for giv­ing flu, Covid-19 vac­cines to el­der­ly in the same vis­it

4 years ago
R&D

Covid-19 roundup: Sin­ga­pore and South Ko­rea are the lat­est to ink sup­ply deals for break­through Covid-19 pill

4 years ago

FDA cen­ter di­rec­tors on lessons from the EUA path­way: Flex­i­bil­i­ty serves us well

4 years ago
FDA+

Covid-19 roundup: Sci­en­tists pull pre-print with in­flat­ed in­ci­dence of my­ocardi­tis post mR­NA vac­cine; As­traZeneca seeks EUA for long-act­ing an­ti­body

4 years ago

Covid-19 roundup: J&J to ap­ply for boost­er au­tho­riza­tion this week as ad­comms are set; BioN­Tech CEO Ugur Sahin pre­dicts need for new vac­cine for­mu­la­tion

4 years ago

Mer­ck claims pan­dem­ic break­through: Covid-19 pill re­duces hos­pi­tal­iza­tion and death by 50%

4 years ago
R&D

Covid-19 roundup: Hu­man er­ror to blame for steel found in Mod­er­na vials; Flu and Covid-19 shots safe to be tak­en to­geth­er — study

4 years ago

With piv­otal da­ta on its Covid-19 an­ti­body in hand, As­traZeneca pre­pares for a mad dash to the FDA

4 years ago
FDA+

Covid-19 roundup: FDA and NIH lead­ers con­tin­ue shar­ing lessons from the pan­dem­ic; Slove­nia halts J&J vac­cine roll­out to in­ves­ti­gate death — re­port

4 years ago

Covid-19 roundup: Pfiz­er/BioN­Tech sub­mit vac­cine da­ta to FDA for younger chil­dren; Doc­tors kept pre­scrib­ing hy­drox­y­chloro­quine

4 years ago

Sanofi calls it quits on mR­NA Covid-19 shots, scrap­ping vac­cine from $3.2B Trans­late Bio buy­out

4 years ago
R&D
First page Previous page 19202122232425 Next page Last page
A service from the Financial Times